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Abstract
Although the nucleotides in tRNA required for aminoacylation are conserved in evolution,
bacterial aminoacyl-tRNA synthetases (aaRSs) are unable to acylate eukaryotic tRNA. The cross-
species barrier may be due to the absence of eukaryote-specific domains from bacterial aaRSs.
Here we show that while E. coli CysRS cannot acylate human tRNACys, the fusion of a eukaryote-
specific domain of human CysRS overcomes the cross-species barrier in human tRNACys. In
addition to enabling recognition of the sequence differences in the tertiary core of tRNACys, the
fused eukaryotic domain redirects the specificity of E. coli CysRS from the A37 present in
bacterial tRNACys to the G37 in mammals. Further experiments show that the accuracy of codon
recognition on the ribosome was also highly sensitive to the A37-to-G37 transition in tRNACys.
These results raise the possibility of the development of tRNA nucleotide determinants for
aminoacylation being interdependent with those for ribosome decoding.
Introduction
The accuracy of translating genetic information into protein sequences is important for
organismal growth and viability, and depending on the complexity of each organism, it is
tightly controlled1. In E. coli, the average protein has ~300 amino acids2, demanding an
error frequency of less than 3 × 10−3 per amino acid, which is supported by experimental
estimations3. In humans, the average protein has ~500 amino acids4 with many involved in
larger complexes, suggesting a need for higher accuracy than that required for E. coli. This
demand is likely true for most eukaryotes, where proteins are typically synthesized as longer
chains with more complexity. Indeed, the accuracy of protein synthesis in the unicellular
eukaryote Saccharomyces cerevisiae is estimated to be ~3-fold higher than that in E. coli5.
The accuracy of protein synthesis is jointly determined by the aaRS-catalyzed tRNA
aminoacylation and by the ribosome-catalyzed tRNA decoding. Each aaRS synthesizes an
aminoacyl-tRNA (aa-tRNA), which enters the ribosome at specific codons for peptide bond
formation. In the progressive organismal evolution into higher complexity, how tRNAs,
aaRSs, and the ribosome adapted to one another is an important question. Relevant to this
question is the frequently observed cross-species barriers to aminoacylation, which block
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bacterial aaRSs from acylating their eukaryotic tRNAs, despite conservation of the
“identity” nucleotides (e.g., the anticodon sequences). The existence of barriers suggests the
emergence of eukaryote-specific tRNA determinants possibly to meet the demand for higher
accuracy of protein synthesis. Notably, eukaryotic aaRSs are more elaborate than their
bacterial counterparts6, possessing extension domains in addition to the core domains for
aminoacylation. While the extension domains are not essential for aminoacylation, some can
enhance aminoacylation specificity over that of bacterial enzymes7. Additionally, eukaryotic
ribosomes have expanded from their bacterial counterparts to include new proteins and RNA
segments that are implicated in cellular control processes unique to eukaryotes. The
expansion of both aaRSs and ribosomes in eukaryotes raises the possibility for the
development of eukaryote-specific tRNA determinants interdependent on aminoacylation
and translation. However, while eukaryotic tRNA nucleotides that act as cross-species
barriers have been studied in some cases (e.g. tRNACys, tRNATyr, and tRNALys)8–10,
whether they function to adapt with the expansion of aaRSs and ribosomes has not been
tested. Also, while replacement of a bacteria-specific peptide in E. coli TyrRS (eTyrRS)
with a eukaryote-specific peptide from human TyrRS (hTyrRS) overcomes a cross-species
barrier11, whether this barrier is linked to the demand for higher accuracy of protein
synthesis in eukaryotes is unknown.
A cross-species barrier exists in aminoacylation of tRNACys. The major determinants for
CysRS reside in the U73 nucleotide at the 3' end of tRNACys and in the GCA
anticodon7,12,13, both of which are strictly conserved in bacteria, eukarya, and even in
archaea14,15. However, eCysRS and several other bacterial CysRS, while able to acylate
each other’s tRNA, are unable to efficiently acylate tRNACys in humans8, indicating the
presence of a eukaryote-specific barrier in htRNACys. The barrier8 is localized to the tRNA
tertiary core and to nucleotide 37 in htRNACys. In the tertiary core, while htRNACys uses the
normal Levitt base pair G15-C48 to join the D and variable loops16, etRNACys uses a rare
G15-G48 base pair17,18, which is recognized by eCysRS in an indirect readout mechanism
that monitors the backbone structure of the base pair18 (Supplementary Fig. S1a,b).
Structural probing shows that the shape of the core in etRNACys as defined by the unusual
G15-G48 is similar to the shape of the core in other bacterial tRNACys using different 15–48
base pairs19. At nucleotide 37, the base is conserved as an A in bacteria and in yeast, but is
conserved as a G in higher eukaryotes. In the tRNA-bound co-crystal structure18, eCysRS
only makes contact with the ribose of A37 (Supplementary Fig. S1c), indicating another
example of indirect readout. However, because the tertiary core and nucleotide 37 are
physically separated, whether their indirect readout mechanisms are coupled or independent
of each other is unknown.
While eCysRS is unable to cross-acylate htRNACys, hCysRS efficiently cross-acylates its
bacterial tRNA8. The human enzyme shares high homology with eCysRS throughout the
core domains18, but contains three eukaryote-specific extensions, of which only the C-
terminal extension (CTE) is broadly conserved in eukaryotes. The CTE enhances
aminoacylation specificity of hCysRS relative to eCysRS7, suggesting that it may mediate
the transition of the translational apparatus from bacteria to humans.
Here we present a comprehensive analysis of the human CTE and its role in the
development of eukaryote-specific tRNA determinants interdependent on aminoacylation
and ribosome decoding. The analysis consists of the construction of a CTE-fused eCysRS,
demonstrating that the fusion overcomes the barrier at both the tertiary core and at
nucleotide 37, and the analysis of eukaryote-specific nucleotides for tRNA selectivity on the
ribosome, demonstrating that G37 in htRNACys imparts increased selectivity relative to A37
in etRNACys at both the initial selection and proofreading stages. We also show that G37 has
become a eukaryote-specific major determinant of aminoacylation, illustrating a principle of
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interdependent development of G37 required for both aminoacylation and ribosome
decoding. We suggest that this interdependency can increase the accuracy of protein
synthesis in eukaryotes relative to bacteria, and that it has implications for the maintenance
of the genetic code stability in eukaryotes.
Results
Fusion of eCysRS overcomes the cross-species barrier
A fusion protein “eCysRS+CTE” was created, in which the sequence of eCysRS was
extended at the C-terminus with the sequence of the human CTE. This fusion markedly
improved aminoacylation of htRNACys by eCysRS, elevating the catalytic efficiency kcat/
Km from ~600-fold below to ~30-fold below that observed with hCysRS (Fig. 1a,b;
Supplementary Table S1). The improvement of activity by the fusion was even more
pronounced in single turnover assays, where the effect of the fusion on the aminoacylation
rate constant (kchem) and on the tRNA affinity constant (Kd) was significant. Analysis of
kchem/Kd showed that the fusion increased aminoacylation of htRNACys by eCysRS from
~700-fold to ~10-fold below that observed with hCysRS (Fig. 1c). In both assays, the fusion
protein acted similarly to hCysRS by retaining full activity to aminoacylate etRNACys.
The fusion protein provided a simpler model than the full-length hCysRS to address how the
CTE removes the cross-species barrier for eCysRS. Using htRNACys as the substrate, we
tested if the fusion protein recognized the eukaryote-specific nucleotides in a way that
paralleled hCysRS. We showed that the determinants in htRNACys that are conserved in
etRNACys lack such differentiation among the three enzymes. For example, the conserved
U73 is the most important nucleotide for tRNA aminoacylation with cysteine7, 8, whose
substitutions are typically discriminated by CysRSs by 104–105-fold based on the kcat/Km
ratio for wild-type (wt) over mutant tRNAs. Indeed, eCysRS, hCysRS, and the fusion
protein all strongly discriminated against the U73A mutation, showing discrimination
factors of 2.0, 16, and 7.2 × 104, respectively (Fig. 2a, Supplementary Table S2). The
degrees of discrimination by the three enzymes is similar, confirming that U73 is not unique
to htRNACys. G34 of the conserved anticodon is the second most important nucleotide for
aminoacylation7, whose mutations are typically discriminated by 102–103-fold. Analysis of
the G34C mutation showed similar discrimination by eCysRS and by the fusion protein (2.0
and 2.9 × 103, respectively) but much greater discrimination by hCysRS (27 × 103) (Fig.
2b). The weak discrimination by the bacterial and fusion enzymes indicates that they
recognize G34 similarly and that G34 is not a eukaryote-specific nucleotide.
Discrimination of the tertiary core is typically by 10–100-fold7,20,21. Alteration of the
normal G15-C48 in the human core to G15-G48 was discriminated by 11-fold by eCysRS,
127-fold by hCysRS, and 85-fold by the fusion protein (Fig. 2c). The close similarity
between hCysRS and the fusion enzyme indicates that the latter had captured the ability of
hCysRS to more strongly recognize the G15-C48 base pair than eCysRS. Similarly,
discrimination of the G37A mutation in the anticodon loop of htRNACys was 0.15 × 104-
fold for eCysRS but much stronger, 24 and 13 × 104-fold, for hCysRS and the fusion
enzyme (Fig. 2d), indicating that the human and fusion enzymes behaved similarly with an
~100-fold higher discrimination relative to eCysRS. Together these results showed that the
fusion enabled eCysRS to recognize the human-specific tertiary core and G37 of htRNACys.
Additionally, mutational analysis of G37 revealed that the level of discrimination against the
G37A mutation by hCysRS and the fusion protein is as strong as that against the U73A
mutation (16 × 104-fold, Fig. 2a, d), suggesting that G37 has emerged as a eukaryote-
specific key determinant equally important as the conserved U73 for aminoacylation of
htRNACys.
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Coordination of the core and G37 in the barrier
Additional analysis (Supplementary Table S3, Supplementary Fig. S2) revealed that the
recognition of the core and G37 in htRNACys is coordinated by the CTE and that the
possession of the CTE conferred upon the human and the fusion enzymes two features
absent from eCysRS. First, both hCysRS and the fusion enzyme have the flexibility to also
recognize A37 in the context of the E. coli core. While both strongly discriminated against
G37A in htRNACys (mutant htRNA-hM1), both also acylated the A37-containing etRNACys
(etRNA-wt) with high efficiency, indicating an ability to recognize G37 in the context of the
human core and to recognize A37 in the context of the E. coli core. In contrast, the CTE-
lacking eCysRS is unable to recognize G37 when associated with the human core. Efficient
aminoacylation of htRNACys by eCysRS occurred only after introduction of G37A and
extensive remodeling of the human core (mutant htRNA-hM2), the latter of which includes
G15-G48 and specific substitutions in the D and variable loops8. Second, the CTE in the
human and fusion enzymes renders the coordinated recognition of G37 with the human core
much stronger than the coordinated recognition of A37 with the E. coli core. While both the
human and fusion enzymes discriminated against G37A in the context of the human core by
105–106-fold (htRNA-wt versus htRNA-hM1), they discriminated against A37G in the
context of the E. coli core by only 103-fold (etRNA-wt versus etRNA-eM1). The
coordinated recognition is also evident in eCysRS, albeit weaker with only a 103-fold
discrimination against A37G in the context of the E. coli core (etRNA-wt versus etRNA-
eM1). Together, these results show that the cross-species barrier is associated with
coordinated changes of the core and nucleotide 37 in the transition from etRNACys to
htRNACys, and that the CTE is required to accompany this transition in the development
from eCysRS to hCysRS.
Higher codon selectivity of htRNACys than etRNACys
We next examined the codon selectivity of etRNACys and htRNACys on the ribosome. The
accuracy of codon recognition is governed in two stages (Fig. 3a): initial selection and
proofreading22–25. Initial selection begins with the entry of an aa-tRNA in a ternary complex
with EF-Tu and GTP to the ribosome, allowing the sorting of the tRNA by codon-anticodon
sampling. Correct pairing leads to rapid GTP hydrolysis26–28, whereas near-cognate pairings
hinder GTP hydrolysis and non-cognate pairings are rejected from the ribosome29. GTP
hydrolysis is irreversible and sets the stage for proofreading, where cognate aa-tRNA is
accommodated for rapid peptide bond formation, whereas near-cognate ones are rejected.
Because selectivity in both stages is largely controlled by kinetics22–24, we used kinetic
assays with the E. coli ribosome22–24. Mammalian ribosomes have not been developed with
such assays.
Selectivity at the initial stage was assayed by the release of Pi from hydrolysis of GTP upon
recognition of a cognate codon-anticodon pairing. Each tRNA was prepared by in vitro
transcription and used in the form of Cys-tRNACys in complex with Tu and GTP. A 70S
ribosome with fMet-tRNAfMet in the P site was programmed with a synthetic mRNA to
place at the A site the cognate codon for cysteine (UGC) or one of three near-cognate (CGC,
UAC, UGG) codons. Each complex was rapidly mixed with a purified ternary complex to
allow measurement of GTP hydrolysis at 3 µM ribosome (Table 1), which was ~2-fold of
the Km of etRNACys or htRNACys for the ribosome (Table 2). Discrimination of etRNA at
the cognate codon (kapp of 13 ± 1 s−1) against the 2nd-position and 3rd-position near-
cognate codons (kapps of 0.013 ± 0.003 and 0.033 ± 0.006 s−1, respectively) was apparent at
a level similar to the discrimination reported for other tRNA30. However, discrimination
against the 1st-position near cognate codon (4.5 ± 0.4 s−1) was relatively weak. A similar
pattern was observed with htRNA, in which the kapp for the cognate codon (2.9 ± 0.3 s−1)
was significantly faster than the kapps for the 2nd-position and 3rd-position near-cognate
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codons (0.0022 ± 0.0004 and 0.010 ± 0.003 s−1, respectively), but only slightly faster than
the kapp for the 1st-position near-cognate (0.06 ± 0.01 s−1). Notably, while both tRNAs were
weak at discriminating against the 1st-postiion near-cognate codon, htRNA was 17-fold
more discriminative.
The selectivity of cognate against the 1st-position near-cognate codon was determined by
analysis of kapp at increasing ribosome concentrations (Table 2, Supplementary Fig. S3).
This revealed that the Km of each tRNA on the ribosome was similar, whereas the saturating
rate constant kGTP varied. Analysis of the specificity constant kGTP/Km between cognate and
near-cognate codons showed that the selectivity of htRNACys (ratio of 44) was 7.7-fold
higher than the selectivity of etRNACys (ratio of 5.7). The lower selectivity of etRNACys
was not due to the lack of nucleotide modifications in the transcript, because native
etRNACys increased the selectivity from a ratio of 5.7 to 9.0, still 5-fold lower than the
selectivity of htRNACys. The modest gain in selectivity with native etRNACys may be
attributable to the natural modification 2-methylthio-N6-isopentenyl (ms2i6) of the A37
base31.
Higher selectivity of htRNACys conferred by G37
To determine whether it was the human core or the G37 being responsible for the higher
selectivity of htRNACys, two mutants of etRNACys were created (Table 2, Supplementary
Fig. S2, Supplementary Figure S4): eM1 harbored the single A37G substitution and eM5
harbored additional substitutions to recapitulate features of the human core. The A37G
substitution alone elevated the selectivity of etRNACys to 57, similar to that of htRNACys,
while the additional substitutions in the eM5 mutant made no further improvement
(selectivity of 50). Thus, G37 alone is sufficient to elevate the selectivity of etRNACys to
that of htRNACys. The selectivity exhibited by the A37G substitution in etRNACys is 10-fold
higher than that of etRNACys-wt, an effect similar to others induced by a single nucleotide
substitution of tRNA (Supplementary Table S4).
We tested the role of G37 in the proofreading stage of decoding by monitoring peptide bond
formation. The etRNACys-eM1 mutant was chosen for comparison with etRNACys-wt,
because the mutant had the same sequence context as the etRNACys-wt except for the A37G
substitution, while showing the same selectivity as htRNACys-wt in the GTPase assay. A
70S ribosome with fMet-tRNAfMet in the P site was programmed with a synthetic mRNA to
place at the A site the cognate (UGC) or near-cognate (CGC) codon. Each complex was
rapidly mixed with a ternary complex to allow measurement of fMet-Cys formation (Fig. 3b,
c, Table 3). At the cognate codon, the apparent rate constant (kapp) of etRNA-wt (1.6 ± 0.2
s−1) was similar to the values measured by others24,32, while the kapp of the eM1 mutant
(0.31 ± 0.06 s−1) was slower. At the near-cognate codon, the kapp of etRNA-wt (0.0011 ±
0.0001 s−1) was substantially decreased and the value of the mutant was too low to be
precisely determined.
Selectivity of proofreading was determined from the amplitude of dipeptide formation per
ternary complex loaded to the ribosome23,24,33,34. The selectivity of etRNA-wt at the
cognate codon (0.46) and near-cognate codon (0.40) was similar, indicating that
discrimination did not occur at the peptide formation step for the wt tRNA. In contrast, the
selectivity of the etRNA-eM1 mutant at the cognate codon (0.17) was more than 5-fold
greater than at the near-cognate codon (0.03). Thus, the mutant exhibited discrimination at a
step where the wt tRNA was incapable of discrimination. From the ratio between the
cognate and near-cognate values, the selectivity of proofreading was 1.2 for etRNA-wt and
5.7 for etRNA-eM1, demonstrating a 4.8-fold increase in fidelity of the mutant. The overall
selectivity improvement of the eM1 mutant relative to etRNA-wt, calculated as the product
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of the improvement in the initial selection (10-fold) and in the proofreading (~5-fold), was
~50-fold.
Discussion
Using the cross-species barrier of cysteinylation of tRNA as a framework, we have provided
a first line of evidence supporting the hypothesis that, due to the expansion of the
translational apparatus that accompanies organismal development, the tRNA component of
the apparatus has developed discrete determinants interdependent on aminoacylation and
decoding. The cross-species barrier in htRNACys is localized to the G15-C48 tertiary core
and to the mammal-specific G37 in the anticodon loop. Fusion of eCysRS with the human
CTE overcomes the barrier at both regions and, more importantly, it re-directs the landscape
of tRNA recognition such that G37 has become a major determinant for aminoacylation, as
important as the conserved U73. The significance of G37 to the fusion protein far exceeds
the significance of A37 to the bacterial enzyme. Using the E. coli ribosome, we then showed
that the single A37-to-G37 transition in etRNACys confers a 10-fold increase in initial
selectivity and an additional 5-fold increase in proofreading, indicating the capacity for a 50-
fold increase in the overall accuracy of decoding.
The increase in initial selectivity by the A37G mutation is demonstrated in tRNA transcripts.
In their native forms, A37 in etRNACys is modified to ms2t6 A37 and G37 in htRNACys is
modified to m1 G37. Both modifications can further increase tRNA selectivity on the
ribosome35, suggesting that the higher accuracy displayed by htRNACys relative to
etRNACys in the transcript form should maintain in the native form. We were unable to
assess decoding accuracy of the two tRNAs using rabbit reticulocyte ribosome, and we
considered yeast ribosome unsuitable, because it presumably co-adapted with yeast
tRNACys, which harbors A37. However, because the nucleotides that control accuracy of
decoding in the ribosome are strictly conserved, the results with the E. coli ribosome
strongly suggest that the A37-to-G37 transition will confer higher selectivity on the human
ribosome.
Crystal structures of bacterial ribosomes reveal that the accuracy of initial selection is
controlled by an induced-fit process of the 30S, involving three strictly conserved
nucleotides in the 16S rRNA to closely monitor the geometry of codon-anticodon
interactions26,36,37. The three conserved nucleotides are also implicated in the proofreading
stage by monitoring the entire anticodon loop structure of tRNA38. Nucleotide 37 is
localized in a dense network of interactions between the three conserved nucleotides,
suggesting that any change in and around the network can result in rearrangement of the
contacts and affect the overall accuracy of decoding. The nature of how the A37-to-G37
transition in etRNACys increases accuracy of decoding is unknown, due to the lack of crystal
structures of ribosome-tRNACys complexes. The A37-to-G37 transition may increase
accuracy by limiting the rearrangement of the contacts to respond only to cognate codon-
anticodon interactions. Although the effect of the A37-to-G37 transition may depend on the
sequence context of the anticodon loop, examples of this transition are abundant in tRNA
databases: the frequency of G37 in tRNA increases from 12% in bacteria to 29% in humans,
while that of A37 decreases from 88% to 70% (Supplementary Table S5), indicating a shift
of preference from A37 to G37.
Recognition of the A37-to-G37 transition for aminoacylation requires the CTE, which
coordinates the transition with changes of the tertiary core. Without the CTE, the
coordination still exists but is 103-fold weaker for eCysRS relative to the fusion protein and
hCysRS. Structural modeling suggests that the CTE is well suited to perform the
coordination, as it emanates from the terminus of the anticodon-binding domain and can
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reach up to a solvent-accessible channel between the stem-contact fold and the inner corner
of the core. Coordinated recognition by the CTE is mediated by indirect readout and is likely
secured by the extensive and complementary enzyme-tRNA interface already present in the
eCysRS-tRNA structure18. The CTE is unique to eukaryotic CysRS, present from yeast to
humans, with no sequence homology to any other protein domains. The specificity of the
CTE to CysRS is illustrated by the analysis of a CTE-fusion to eMetRS, a close structural
homolog of eCysRS. While the native eMetRS is able to acylate the bacterial but not the
eukaryotic tRNAMet, illustrating the existence of a cross-species barrier; the CTE fusion to
eMetRS does not overcome the barrier but instead impairs the enzyme activity with bacterial
tRNAMet (Supplementary Fig. S5).
Our work suggests a model consistent with the A37-to-G37 transition being interdependent
on both aminoacylation and ribosome decoding (Fig. 4). This transition would occur only
concomitantly with the development of the CTE in human CysRS as an appendage to the
core domains in bacterial CysRS. Using an indirect readout mechanism, the CTE would
reach around from the anticodon loop all the way to the top of the tertiary core, where it
enforces recognition of the human core. To secure the presence of G37 in humans, the CTE
would redirect the human CysRS to adopt G37 as a major determinant for aminoacylation.
The absence of the CTE from bacterial CysRSs explains their inability to recognize the A37-
to-G37 transition.
The conservation of A37 in bacterial tRNACys has important implications. First, calculation
of the error frequency of the A37-bearing etRNACys from the kapp of dipeptide synthesis at
near-cognate (0.001 s−1) and cognate (1.6 s−1) codons reveals a value of 0.6 × 10−3,
consistent with the error frequency reported for other bacterial tRNA24. At this error
frequency, the fidelity of etRNACys is sufficient for faithful synthesis of an average protein
in bacteria, suggesting that higher accuracy is not necessary. Second, even if the A37-to-
G37 transition had occurred by a single-site nucleotide substitution among bacterial species
over time, the resulting tRNA mutant would be unrecognizable to bacterial CysRS, due to
the lack of the CTE. Development of the CTE, with more than 100 amino acids in specific
structural arrangements, is arguably more difficult than the single nucleotide substitution in
tRNA. Third, addition of the CTE to bacterial CysRS is not beneficial, because it would
slow down the rate of aminoacylation and incur disadvantage to bacteria. Note that the CTE
fusion of eCysRS delays kchem (9.5 ± 0.4 s−1) by 2-fold in single turnover assays relative to
the unfused enzyme (15.2 ± 0.5 s−1), and also delays kcat (0.44 ± 0.02 s−1) by 2.5-fold in
steady state relative to the control (1.0 ± 0.1 s−1). Reduced rates of aminoacylation are
harmful to bacteria particularly during rapid cell growth. In the case of hCysRS, while the
native enzyme exhibits a slower kchem (20 ± 1 s−1) than a °C mutant lacking the CTE (~120
s−1), there is an advantage in having the CTE, because the specificity of tRNA
aminoacylation of the native enzyme is higher than that of the mutant7. Thus, hCysRS
would benefit from a trade-off between speed and accuracy by having the CTE.
In mitochondria, tRNACys is strictly conserved with A37 from yeast to humans and the
occurrence of A37 remains stable (25.93% in yeast and 22.22% in humans, Supplementary
Table S6). In addition, mitochondrial CysRSs consistently lack the CTE, suggesting that
aminoacylation of tRNACys by these enzymes is operated by a bacteria-like mechanism.
Because mitochondrial CysRSs are nuclear-encoded, this bacteria-like mechanism would
prevent cross-acylation of the cytosolic G37-bearing tRNACys during their transient
residence in the cytoplasm before import into mitochondria. The compartment-specific
acylation should prevent two enzymes from acylating the same tRNA, a situation that would
promote errors and challenge the stability of the genetic code39.
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Cross-species barriers to aminoacylation are widespread among aaRSs. At least for the
CysRS enzymes, an interdependent relationship exists between tRNA aminoacylation and
tRNA decoding on the ribosome, involving the development of a specific domain in the
evolution of CysRS from bacteria to humans. Certainly analysis of other members of the
aaRS family for interdependent relationships of tRNA aminoacylation and decoding will be
necessary to gain a broader insight into the evolution of these enzymes and their role in the
maintenance of the genetic code stability.
Methods
Reagents
The gene for the eCysRS+CTE fusion protein was generated by inserting the coding
sequence of the CTE of hCysRS7 (from V642 to Q748) into the eCysRS clone40 at the
BamHI site, such that expression of the fusion extended the C-terminal K461 of eCysRS
with the sequence of the CTE. Recombinant His-tagged eCysRS, hCysRS, and eCysRS
+CTE were each expressed at 37 °C in BL21(DE3) upon induction with 0.4 mM IPTG and
were purified using Talon resin, followed by chromatography through a Mono Q column on
an Akta FPLC. Enzyme concentrations were measured by Bradford assay with BSA as the
standard, and corrected by active site burst assay41. Unmodified transcripts of tRNAs were
prepared by in vitro transcription with T7 RNA polymerase from DNA templates generated
by primer extension of overlapping olignucleotides. After denaturing gel purification and
ethanol precipitation, tRNA transcripts were determined for concentration by absorption at
260 nm and by plateau charging. Tight-coupled ribosomes were prepared from E. coli
MRE600 cells, while E. coli His-tagged EF-Tu, IF1, IF2, and IF3 were affinity purified42.
The mRNA sequence for translation was the 022 sequence, encoding 5'-GGG-AAG-GAG-
GUA-AAA-AUG-XXX-GUU-CTA-UAC-AAG-ACU-CAC-CAC-CAC-CAC-CAC-3',
where the underline and bold face letters indicate the Shine-Delgarno sequence and the
initiation codon, respectively, and XXX indicates the triplet sequence of the cognate and
near-cognate codons for cysteine. This sequence was chosen because its initiation region
confers high expression levels in E. coli43. Each mRNA was synthesized by in vitro
transcription from a T7 promoter.
Aminoacylation
Steady-state assays40 were performed at 37 °C in a buffer containing 20 mM Tris-HCl, pH
7.5, 20 mM KCl, 10 mM MgCl2, 25 mM DTT, 2 mM ATP, 50 µM 35S-cysteine with 0–120
µM tRNA, and 0–4 nM of CysRS. The Km (tRNA), kcat, and kcat/Km values for each tRNA
and enzyme were derived from fitting the data to Michaelis-Menten equation. The kcat/Km
data for the G37A mutant was estimated from initial rate of aminoacylation under sub-Km
concentrations of the tRNA substrate (40 µM) with 10 µM enzyme. Single-turnover assays
were performed similarly but with CysRS in excess of tRNA44 on the RQF-3 KinTek
instrument.
GTP hydrolysis
GTPase reactions were performed with 7 mM MgCl2 intermediate between 3.5 mM MgCl2
of HiFi buffer and 20 mM MgCl2 of LoFi buffer23. This buffer was chosen because it
conferred higher stoichiometry in complex formation and faster rates compared with the
HiFi buffer. Ternary complex was formed by activating 2 µM EF-Tu with 8 nM γ-32P-GTP
(6,000 Ci/mmole) for 15 min at 37 °C after which Cys-tRNACys was added to 1.0 µM and
the incubation continued for 15 min at 4 °C. Free GTP was removed from the ternary
complex by a Centrispin-20 spin. The 70S Initiation complex (70SIC) was formed by
incubating 1–6 µM 70S ribosome with a 1.5-fold molar excess of IF1, IF2 and IF3 and a 2-
fold excess of native fMet-tRNAfMet and mRNA with 1 mM GTP for 25 min at 37 °C.
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Titration of initiation factors relative to the ribosome showed a consistent stoichiometry of
0.7 for fMet-tRNAfMet bound per ribosome. Titration of a ternary complex relative to the
70SIC also showed a stoichiometry of 0.7 for each complex per 70SIC. Aliquots of the
mixture of a ternary complex and 70SIC were quenched in acid, followed by reaction with
sodium molybdate, and extraction with ethyl acetate42. Analysis of kapp versus ribosome
concentration fit to a hyperbola (R2 > 0.98) to yield Km and kGTP. Assays with native
etRNACys were performed with a crude mixture of E. coli tRNAs isolated from an over-
producer strain that generated Cys-etRNACys as 5–7% of total tRNA. The strong affinity of
EF-Tu for aa-tRNA over tRNA provided the selectivity for loading Cys-etRNACys to the
ribosome. Native fMet-tRNAfMet was prepared similarly, except that aminoacylation with
MetRS was done in the presence of methionyl formyl transferase and N10-
formyltetrahydrofolate.
Peptide bond formation
Assays were performed by mixing 70SIC (1.0 µM 70S ribosome, 1.5 µM IF1, IF2 and IF3,
1.0 µM 35S-fMet-tRNAfMet, 2 µM mRNA and 1 mM GTP in Buffer A (50 mM Tris-HCl,
pH 7.5, 70 mM NH4Cl, 30 mM KCl, 7 mM MgCl2, and 10 mM DTT) and ternary complex
(1 µM EF-Tu, 0.5 µM Cys-tRNACys and 1 mM GTP in Buffer A) at 25 °C. Aliquots were
quenched in acid and analyzed by electrophoretic TLC45. The fraction of 35S-fMet
converted to dipeptide was plotted as a function of time. Single exponential fitting of the
plots yielded apparent rate constants for peptide bond formation. If reactions were in
multiple turnover conditions, the data would not fit to a single exponential equation. The
slow reactions at the near-cognate codon were not due to recycling of Cys-tRNACys,
because once Cys-tRNACys left EF-Tu-GTP it could not re-bind to EF-Tu, which would
have hydrolyzed GTP to GDP in the absence of a bound aa-tRNA46. Neither were the slow
reactions at the near-cognate codon due to hydrolysis of Cys-tRNACys, which would have
shown the same plateau level for both the wt and eM1 mutant tRNA.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Aminoacylation of tRNACys with cysteine. (a) Sequences of transcripts of etRNACys and
htRNACys, showing the conserved U73 and GCA anticodon for aminoacylation and the non-
conserved determinants at position 15–48 in the tertiary core and at base 37 in the anticodon
loop. (b) Steady-state activity (kcat/Km) of aminoacylation of etRNACys and htRNACys by
CysRS enzymes. (c) Single turnover activity (kchem/Kd) of aminoacylation of etRNACys and
htRNACys by CysRS enzymes. Data are shown in a logarithmic scale and are the average of
3 determinations. Error bars represent standard deviations.
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Discrimination against mutations in htRNACys. (a) Discrimination against the U73A
mutation. (b) Discrimination against the G34C mutation. (c) Discrimination against the G15-
G48 mutation. (d) Discrimination against the G37A mutation. Data were obtained by
analysis of the steady-state kcat/Km. Each point was the average of 3 determinations and
error bars represented standard deviations.
Liu et al. Page 13














Codon recognition on the ribosome. (a) A scheme of codon recognition, showing initial
selection of tRNA in the first stage, which is assayed by GTP hydrolysis, followed by
proofreading in the second stage, which is assayed by peptide bond formation. (b) Time
courses of dipeptide formation on etRNA-wt on UGC (cognate) or CGC (near-cognate)
codons measured with a limiting concentration of the ternary complex (0.25 µM). (c) Time
courses of dipeptide formation on etRNA-eM1 harboring the A37G mutation on UGC or
CGC codon measured with a limiting concentration of the ternary complex (0.25 µM). Data
in (b) and (c) were obtained in single turnover conditions and were well fit to a single
exponential equation and plotted on a semi-log scale.
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A model of interdependent development of tRNACys nucleotides. Center: The A37-to-G37
transition (an open circle to a black circle) from etRNACys (orange) to htRNACys (green) is
proposed to couple with the transition from the G15-G48 tertiary core (a dashed line) in E.
coli to the G15-C48 tertiary core (a solid line) in humans. Right: This coupled development
is concomitant with the CTE fusion to the core domains of eCysRS (dark grey: activation
domain; light grey: tRNA docking domains) to enable recognition of the transition for
aminoacylation. The development process also recruits two other eukaryote-specific
domains (light blue) to form hCysRS. Left: The A37-to-G37 transition in the coupled
development of tRNA nucleotides confers high codon selectivity on the A site of the
ribosome to satisfy the demand for accuracy of protein synthesis in humans.
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